From Soil to Solution: How Streptomycin is Extracted and Evaluated

Antibiotics remain one of the most important discoveries in medical science, serving as a cornerstone in the fight against infectious diseases from time immemorial. Among them, Streptomycin occupies a special place in history. Streptomycin is an aminoglycoside antibiotic originally isolated from the actinobacterium Streptomyces griseus, a soil-dwelling bacterium. Streptomyces species thrive in rich organic soils, where they secrete streptomycin as a secondary metabolite to inhibit competing bacteria.

Through laboratory isolation and fermentation, the antibiotic can be extracted from the cultured soil microorganisms and purified for medical use. The discovery of streptomycin in 1943 marked the first effective treatment for tuberculosis, a disease that had caused significant morbidity and mortality worldwide. Beyond its role in tuberculosis therapy, streptomycin has proven to be effective against a wide range of Gram-negative bacterial pathogens, including Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa. It functions by binding to the 30S ribosomal subunit of bacteria, interfering with protein synthesis and leading to cell death.

The genus Streptomyces is particularly notable for its remarkable ability to produce diverse secondary metabolites with antimicrobial, antifungal, and antitumor activities. It is estimated that more than two-thirds of naturally derived antibiotics originate from Streptomyces species. Secondary metabolites, unlike primary metabolites essential for growth and reproduction, are typically synthesized under specific environmental conditions or during stationary growth phases of microbial cells. These metabolites confer a competitive advantage in the microbial ecosystem by inhibiting rival microorganisms. Streptomycin exemplifies such a metabolite, and its extraction and evaluation provide an excellent educational model for understanding natural product discovery, microbial ecology, and applied microbiology.

The extraction of antibiotics like streptomycin from microbial cultures involves cultivating the producing organism under suitable conditions, followed by recovery and partial purification of the bioactive compound from the fermentation broth. Evaluation of antimicrobial activity is then commonly conducted using in vitro assays such as the agar well diffusion method. In this method, test organisms are inoculated onto an agar plate, and wells are filled with the extracted antibiotic. Following incubation, zones of inhibition surrounding the wells indicate the antibiotic’s potency and spectrum of activity of the isolated bioactive compound.

Extraction of streptomycin

The production of streptomycin begins with the cultivation of Streptomyces griseus on nutrient-rich media, typically starch casein agar or other actinomycete-specific formulations. The organism is allowed to grow under aerobic conditions, as oxygen is critical for the biosynthesis of its secondary metabolites. Over time, the culture produces streptomycin, which diffuses into the surrounding medium.

To extract streptomycin, the fermentation broth is harvested after sufficient incubation. The culture is filtered to remove microbial cells, leaving a cell-free supernatant containing dissolved metabolites. Solvent extraction or precipitation methods are then employed to isolate the antibiotic. For instance, streptomycin can be precipitated by adjusting the pH and then collected via centrifugation or filtration technique. Additional purification steps, such as solvent partitioning or column chromatography, may be used in research laboratories to obtain a more refined product of the bioactive compound.

Microbial evaluation using the agar well diffusion method

Once extracted, the antimicrobial potential of streptomycin is evaluated against selected test organisms. The agar well diffusion method is one of the most widely used and straightforward assays for this purpose. In this technique, nutrient agar plates are seeded with a standardized inoculum of a bacterial test strain. Wells are then bored into the agar and filled with known volumes of the antibiotic extract.

The plates are incubated under optimal conditions for the growth of the test organism. During incubation, the antibiotic diffuses radially through the agar. If the test organism is susceptible to streptomycin, its growth will be inhibited in the vicinity of the well, resulting in a clear, circular zone of inhibition. The diameter of this zone can be measured and compared to reference values or controls to determine the relative effectiveness of the extracted bioactive compound.

Common test organisms used in such assays include both Gram-positive and Gram-negative bacteria, such as Staphylococcus aureus, E. coli, and Bacillus subtilis. Streptomycin is particularly active against Gram-negative bacteria, though some Gram-positive strains may also show susceptibility.

Significance of the experiment to extract streptomycin 

The extraction and evaluation of streptomycin provide a practical illustration of several important microbiological and pharmacological principles. First, it highlights the natural role of soil microorganisms as prolific producers of antibiotics and underscores the importance of microbial ecology in drug discovery. Secondly it demonstrates the experimental workflow from microbial cultivation, metabolite extraction, and antimicrobial screening – steps that are foundational in pharmaceutical microbiology. Thirdly, the use of the agar well diffusion method introduces students and researchers to a simple yet powerful bioassay technique for measuring antimicrobial activity of (newly isolated) bioactive compounds.

This experiment also has broader implications in the context of modern challenges. With the rise of antimicrobial resistance (AMR), the discovery of new antibiotics or the reevaluation of existing ones is critical. Although streptomycin has been in use for decades and resistance to it is widespread, revisiting such natural products serves as a reminder of the microbial world’s potential as a reservoir of bioactive compounds. Moreover, the methodologies learned through this experiment can be applied to screen for novel antibiotics from environmental isolates, which is particularly important in an era where drug-resistant infections threaten global health.

Streptomycin, a pioneering antibiotic from Streptomyces griseus, exemplifies the importance of microbial secondary metabolites in medicine. Through its extraction and subsequent evaluation using the agar well diffusion method, one can appreciate not only its antimicrobial activity but also the broader processes involved in antibiotic discovery and testing. This experiment offers a valuable educational platform, reinforcing the link between microbiology, natural products chemistry, and clinical therapeutics, while also emphasizing the continuing relevance of antibiotic research in addressing contemporary health challenges.

Aim of the experiment

The aim of this experiment is to extract streptomycin from a culture of Streptomyces griseus and evaluate its antimicrobial activity against selected bacterial strains. This process demonstrates both the natural production of antibiotics by soil microorganisms and their effectiveness against clinically relevant pathogens.

Streptomyces griseus culture: The antibiotic-producing microorganism, S. griseus, is the source of streptomycin. Its ability to synthesize secondary metabolites makes it an ideal candidate for antibiotic extraction studies. S. griseus is isolated from soil.

Steps in the extraction of streptomycin from soil

1. Soil sample collection and pretreatment: Collect approximately 1 g of soil from sites rich in decomposing organic material, such as compost, forest soil, or agricultural soil. Place the sample in a clean container and allow it to air-dry at room temperature for 24-48 hours. This pretreatment reduces the abundance of rapidly growing microorganisms and favors the recovery of relatively slow-growing actinomycetes such as Streptomyces.

2. Serial dilution of the soil sample: Transfer 1 g of the dried soil into 9 mL of sterile distilled water and mix thoroughly to obtain a 10⁻¹ dilution. Prepare successive tenfold dilutions to approximately 10⁻⁵ or 10⁻⁶. Serial dilution reduces the microbial concentration and increases the likelihood of obtaining well-separated colonies after plating.

3. Selective plating: Transfer an appropriate volume from selected dilutions onto actinomycete-selective media, such as starch-casein agar, glycerol-asparagine agar, or actinomycete isolation agar. Selective supplements may be used according to the validated medium formulation to reduce the growth of competing bacteria and fungi. Spread the inoculum evenly over the agar surface using sterile technique.

4. Incubation and observation: Incubate the inoculated plates under conditions appropriate for Streptomyces isolation, commonly around 28-30°C. Because Streptomyces colonies develop relatively slowly, plates may require extended incubation. Examine the plates periodically for colonies exhibiting characteristic actinomycete morphology, including dry, chalky, leathery, powdery, or filamentous growth.

5. Purification of the isolate: Select well-separated colonies displaying typical Streptomyces-like characteristics and transfer them to fresh agar medium. Repeated subculturing of individual colonies helps establish a pure culture. Purity should be assessed by consistent colony morphology and microscopic examination.

6. Identification of Streptomyces griseus: Characterize the purified isolate by examining colony morphology, pigmentation, aerial and substrate mycelium, and spore formation. Microscopic examination can provide additional evidence of Streptomyces characteristics. For species-level confirmation, molecular identification such as 16S rRNA gene sequencing may be performed. Because morphology alone cannot reliably establish S. griseus identity, molecular or additional taxonomic analysis is preferable when species-level identification is required.

7. Preparation of the production culture: The confirmed isolate can be transferred into an appropriate production medium containing suitable carbon and nitrogen sources. Starch-casein broth is commonly associated with actinomycete cultivation and can support growth and secondary-metabolite production. Culture conditions should be optimized experimentally because antibiotic production depends on the strain, medium composition, oxygen availability, pH, temperature, and cultivation time.

8. Separation of cells from culture broth: Following cultivation, the culture broth contains both microbial biomass and extracellular metabolites. The biomass can be separated from the liquid fraction by an appropriate clarification method, such as filtration or centrifugation. The clarified aqueous fraction can then be evaluated for antibacterial activity.

9. Recovery and purification of streptomycin: Because streptomycin is a water-soluble aminoglycoside, conventional organic-solvent extraction with ethyl acetate is not an appropriate primary recovery method. Instead, recovery can involve established aqueous purification approaches, such as adsorption/ion-exchange procedures followed by appropriate concentration and purification steps. The resulting fraction should be treated as a crude or partially purified antibiotic preparation unless analytical characterization confirms its identity and purity.

10. Antibacterial activity testing: The antibiotic-containing preparation can be evaluated using an agar diffusion assay on Mueller-Hinton agar. Test organisms such as Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa may be used as laboratory strains where appropriate. Include a standard streptomycin preparation as a positive control and the corresponding solvent or matrix as a negative control. Measure zones of inhibition and compare the results with the controls.

11. Culture maintenance: Maintain confirmed cultures using an appropriate short-term storage method. For longer-term preservation, validated cryopreservation procedures can be used. Proper labeling and documentation of strain identity, source, passage history, and preservation conditions are essential for reproducibility.

Antibacterial testing of the produced streptomycin

The antibacterial activity of the streptomycin produced by Streptomyces griseus should be assessed against selected clinically relevant bacterial species. The selected test organisms should include representative Gram-positive and Gram-negative bacteria to determine the inhibitory activity of the produced antibiotic against different bacterial groups.

An agar diffusion assay should be used to assess the antibacterial activity of the produced streptomycin. In this method, the selected bacterial organisms should be inoculated onto an appropriate agar medium, followed by application of the produced streptomycin preparation to the inoculated plates. A standard streptomycin preparation should be included as a positive control, while a suitable negative control should be used to confirm that any observed inhibition is attributable to the antibiotic preparation.

After incubation, the plates should be examined for zones of inhibition around the test samples. The diameter of each inhibition zone should be measured and recorded as an indication of the antibacterial activity of the produced streptomycin. The results should then be compared with those obtained using the standard streptomycin preparation.

The following steps should be followed to test the antibacterial activity of the produced streptomycin against the selected clinically relevant bacterial isolates.

Preparation of test plates

• Prepare Mueller-Hinton Agar (MHA) by dissolving the required amount of dehydrated medium in distilled water.

• Sterilize the medium in an autoclave at 121 °C for 15 minutes.

• Cool the medium to 45-50 °C and pour 20-25 mL into sterile Petri dishes.

• Allow the agar to solidify under aseptic conditions in a laminar airflow chamber.

Preparation of test organisms

• Grow overnight cultures of Escherichia coli (Gram-negative), Pseudomonas aeruginosa (Gram-negative), and Staphylococcus aureus (Gram-positive) in nutrient broth at 37°C.

• Adjust cultures to approximately 0.5 McFarland standard to standardize bacterial density.

Inoculation of agar plates

• Dip a sterile cotton swab into the standardized bacterial suspension.

• Remove excess inoculum by rotating the swab against the inner wall of the tube.

• Streak the agar surface in three directions to obtain a uniform lawn of growth.

• Leave plates for 10-15 minutes to allow absorption of inoculum.

Preparation of wells and application of samples

• Bore uniform wells (≈6 mm diameter) into the agar using a sterile cork borer.

• Maintain equal spacing between wells and avoid penetrating the agar base.

• Label each well according to the test sample.

• Add 50-100 µL of crude streptomycin extract into designated wells using a sterile micropipette.

• Add standard streptomycin solution (positive control) to one well.

• Add the extraction solvent (ethyl acetate or n-butanol) alone as the negative control.

Incubation and observation

• Incubate the plates upright at 37 °C for 18-24 hours.

• Examine plates for zones of inhibition around the wells.

• Measure zone diameters in millimeters using a transparent ruler or digital caliper.

• Compare inhibition zones of test samples with the positive control to assess potency.

• Confirm that the negative control shows no inhibition.

Expected results

When the agar well diffusion assay is performed using the extracted streptomycin, clear zones of inhibition are expected to form around the wells containing the antibiotic extract. These zones represent areas where the growth of the test bacteria has been suppressed due to the antimicrobial action of streptomycin. The diameter of each zone serves as a direct indicator of the potency and effectiveness of the extracted compound.

Larger inhibition zones typically correspond to higher activity and suggest a greater concentration or purity of the antibiotic, whereas smaller zones may indicate weaker antimicrobial effects, potentially due to lower concentrations of the active metabolite or the presence of impurities that interfere with activity. It is also anticipated that the size of the inhibition zones will vary depending on the test organism used.

Gram-negative bacteria such as Escherichia coli and Pseudomonas aeruginosa are generally more susceptible to streptomycin than many Gram-positive species. Plates seeded with susceptible Gram-negative bacteria are expected to display more pronounced and wider zones of inhibition compared to those inoculated with Gram-positive strains. In addition, slight variations in zone sizes may be observed across replicates due to natural variability in diffusion rates, agar thickness, and microbial inoculum density.

Interpretation of the expected results

The presence of clear inhibition zones surrounding the wells strongly suggests that the streptomycin extract retains antimicrobial activity against the tested organisms. A comparative analysis with controls is crucial to validate these findings. The positive control, usually a commercially available antibiotic standard, is expected to produce well-defined inhibition zones. If the zones produced by the streptomycin extract are comparable in size to those of the positive control, this confirms the successful recovery of an active compound with significant antimicrobial potential. 

Even if the zones are slightly smaller than the control, the result remains meaningful, as it reflects that the crude extract still exhibits biologically relevant activity. The negative control, typically sterile solvent or culture medium without any antibiotic, should show no inhibition zones. The absence of growth inhibition in this control validates the reliability of the assay by confirming that the observed antimicrobial effect is solely due to streptomycin and not due to extraneous factors such as solvent toxicity or contamination. Together, these comparisons allow for accurate interpretation of the experiment’s outcome.

The spectrum of activity observed against different organisms can provide additional insights. For instance, strong activity against Gram-negative bacteria but limited effect against Gram-positive strains aligns well with the known pharmacological profile of streptomycin. Such results would reinforce the idea that the experimental extract behaves similarly to the purified commercial drug, thereby confirming both the specificity and functionality of the extraction process.

This experiment will successfully demonstrate both the extraction of streptomycin from Streptomyces griseus and the evaluation of its antimicrobial activity using the agar well diffusion method. This experiment could serve as both a practical demonstration and a reminder of the continued relevance of microbiology in safeguarding public health.

References

Maiti, P. K., Das, S., Sahoo, P., et al. (2020). Streptomyces sp. SM01 isolated from Indian soil produces a novel antibiotic picolinamycin effective against multidrug-resistant bacterial strains. Scientific Reports, 10, 10092.

Quinn, G. A., Banat, A. M., Abdelhameed, A. M., & Banat, I. M. (2020). Streptomyces from traditional medicine: Sources of new innovations in antibiotic discovery. Journal of Medical Microbiology, 69(8), 1040–1048.

Rammali, S., Rahim, A., El Aalaoui, M., et al. (2024). Antimicrobial potential of Streptomyces coeruleofuscus SCJ isolated from microbiologically unexplored garden soil in Northwest Morocco. Scientific Reports, 14, 3359.

Rezzonico, F., Stockwell, V. O., & Duffy, B. (2009). Plant agricultural streptomycin formulations do not carry antibiotic resistance genes. Antimicrobial Agents and Chemotherapy, 53.

Sahar Tolba, S., Egan, S., Kallifidas, D., & Wellington, E. M. H. (2002). Distribution of streptomycin resistance and biosynthesis genes in streptomycetes recovered from different soil sites. FEMS Microbiology Ecology, 42(2), 269–276.

Saravana Kumar, P., Duraipandiyan, V., & Ignacimuthu, S. (2014). Isolation, screening and partial purification of antimicrobial antibiotics from soil Streptomyces sp. SCA 7. Kaohsiung Journal of Medical Sciences, 30(9), 435–446.

Shah, I., Uddin, Z., Hussain, M., Khalil, A. A. K., Amin, A., Hanif, F., Ali, L., Amirzada, M. I., Shah, T. A., Dawoud, T. M., Bourhia, M., Li, W. J., & Sajjad, W. (2024). Streptomyces sp. from desert soil as a biofactory for antioxidants with radical scavenging and iron chelating potential. BMC Microbiology, 24, 419.